Canton Strategic Holdings, Inc. Rebrands, Changes Ticker to CNTN for Digital Asset Strategy
Summary
Tharimmune, Inc. has officially rebranded to Canton Strategic Holdings, Inc. and changed its Nasdaq ticker symbol to CNTN, aligning its corporate identity with its new digital asset treasury strategy.
Key Events · Corporate Governance and Compliance · THAR
-
Corporate Name Change
The company officially changed its corporate name from Tharimmune, Inc. to Canton Strategic Holdings, Inc.
-
Ticker Symbol Change
The Nasdaq ticker symbol for the company's common stock changed from 'THAR' to 'CNTN', effective February 18, 2026.
-
Strategic Alignment
The rebrand is explicitly stated to align with the company's digital asset treasury strategy, focusing on the Canton Network and Canton Coin, a strategy previously detailed in recent filings.
-
Bylaws Amended
The company's bylaws were amended and restated to reflect the new corporate name and the current size of the Board of Directors.
Analysis · THAR · Life Sciences
This 8-K filing formalizes the corporate name change from Tharimmune, Inc. to Canton Strategic Holdings, Inc., and the ticker symbol change from THAR to CNTN, effective February 18, 2026. This rebrand aligns the company's identity with its recently announced digital asset treasury strategy, which includes leveraging Canton Coin and operating as a Super Validator on the Canton Network. This follows a series of significant strategic moves, including the approval as a Super Validator on January 26, 2026, and the closing of a $55 million registered offering on January 22, 2026, to fund this new direction. The name change reinforces the company's commitment to its new focus on institutional blockchain adoption and the digitization of financial markets.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, THAR was trading at $4.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $187.4M. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.